The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients

摘要

Abstract Long noncoding RNAs (lncRNAs), highly upregulated liver cancer (HULC), metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1), lncRNA‐AF085935, and lncRNA‐uc003wbd have been implicated in hepatocellular carcinoma (HCC). Single‐nucleotide polymorphism (SNP) in HULC and MALAT1 are associated with HCC susceptibility. However, association between these SNPs and lncRNA‐AF085935 and lncRNA‐uc003wbd expression and their potential clinical value in differentiating HCC from both hepatitis B virus (HBV)‐infected Egyptian patients and the healthy specimens have not been explored yet. In the present study, SNPs rs7763881 in HULC and rs619586 in MALAT1 were genotyped in 70 HBV‐positive HCC, 70 HBV patients, and 70 healthy controls in Egyptian population and the level of serum lncRNA‐AF085935 and lncRNA‐uc003wbd of all the subjects was assayed by quantitative real‐time polymerase chain reaction. HULC rs7763881 AC/CC genotype was significantly associated with decreased HCC risk. Similarly, AG/GG of MALAT1 rs619586 was associated with decreased HCC risk with a borderline significance. Serum lncRNA‐AF085935 and lncRNA‐uc003wbd levels were upregulated in HBV‐positive HCC and HBV patients vs controls and discriminated these groups by receiver operating characteristic analysis. Patients carrying AC/CC genotype of rs7763881 and AG/GG of rs619586 had lower serum lncRNA‐AF085935 and lncRNA‐uc003wbd levels compared with AA genotype. In conclusion, genetic variants of lncRNA HULC and lncRNA MALAT1 are associated with the decreased susceptibility to HCC in HBV‐persistent carriers and are correlated with serum lncRNA‐AF085935 and lncRNAuc003wbd levels, two potential noninvasive diagnostic biomarkers for HCC.